These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38071626)

  • 1. Pharmacists' role and experiences with delivering mental health care within team-based primary care settings during the COVID-19 pandemic.
    Ashcroft R; Mathers A; Gin A; Lam S; Donnelly C; Brown JB; Kourgiantakis T; Mehta K; Rayner J; Sur D; Adamson K; Kirvan A; Dolovich L
    Int J Pharm Pract; 2024 Mar; 32(2):156-163. PubMed ID: 38071626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Community pharmacists' roles during the closure stage of the COVID-19 pandemic in Newfoundland and Labrador, Canada: a qualitative case study.
    Farooq S; Donnan JR; Lukewich J; Mathews M; Lee TA
    BMJ Open; 2024 Aug; 14(8):e085338. PubMed ID: 39107026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacy Emergency Preparedness and Response (PEPR): a proposed framework for expanding pharmacy professionals' roles and contributions to emergency preparedness and response during the COVID-19 pandemic and beyond.
    Aruru M; Truong HA; Clark S
    Res Social Adm Pharm; 2021 Jan; 17(1):1967-1977. PubMed ID: 32389631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The voices of community pharmacists during the COVID-19 pandemic in Puerto Rico.
    Silva-Suárez G; Alvarado Reyes Y; Hernandez-Diaz A; Rodriguez Ramirez K; Colón-Pratts FM
    J Am Pharm Assoc (2003); 2022; 62(1):202-208.e3. PubMed ID: 34366289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Provision of community pharmacy services during COVID-19 pandemic: a cross sectional study of community pharmacists' experiences with preventative measures and sources of information.
    Hoti K; Jakupi A; Hetemi D; Raka D; Hughes J; Desselle S
    Int J Clin Pharm; 2020 Aug; 42(4):1197-1206. PubMed ID: 32524513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interprofessional primary care during COVID-19: a survey of the provider perspective.
    Donnelly C; Ashcroft R; Bobbette N; Mills C; Mofina A; Tran T; Vader K; Williams A; Gill S; Miller J
    BMC Fam Pract; 2021 Feb; 22(1):31. PubMed ID: 33535973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A roadmap beyond dispensing for educating and training community pharmacists on key mental health competencies: A mixed-methods national study.
    Alzubaidi H; Saidawi W; Goldstone L; Saddik B; Abduelkarem AR; Abu-Gharbieh E; Alzoubi KH; Samorinha C
    Res Social Adm Pharm; 2024 Jun; 20(6):134-145. PubMed ID: 38503576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Benefits and Challenges of Precepting Pharmacy Students Virtually in Interprofessional Primary Care Teams.
    Ashcroft R; Mathers A; Gin A; Lam S; Donnelly C; Brown JB; Kourgiantakis T; Adamson K; Mehta K; Rayner J; Sur D; Kirvan A; Sheffield P; Dolovich L
    Am J Pharm Educ; 2023 Jul; 87(7):100098. PubMed ID: 37380266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The coping strategies of community pharmacists and pharmaceutical services provided during COVID-19 in Malaysia.
    Kua KP; Lee SWH
    Int J Clin Pract; 2021 Dec; 75(12):e14992. PubMed ID: 34710264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A photovoice study on community pharmacists' roles and lived experiences during the COVID-19 pandemic.
    Watson KE; Schindel TJ; Chan JCH; Tsuyuki RT; Al Hamarneh YN
    Res Social Adm Pharm; 2023 Jun; 19(6):944-955. PubMed ID: 36935325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary care teams' experiences of delivering mental health care during the COVID-19 pandemic: a qualitative study.
    Ashcroft R; Donnelly C; Dancey M; Gill S; Lam S; Kourgiantakis T; Adamson K; Verrilli D; Dolovich L; Kirvan A; Mehta K; Sur D; Brown JB
    BMC Fam Pract; 2021 Jul; 22(1):143. PubMed ID: 34210284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-sectional questionnaire study of the experiences of community pharmacists in Northern Ireland during the early phases of the COVID-19 pandemic: preparation, experience and response.
    Patterson SM; Cadogan C; Barry HE; Bennett KE; Hughes C
    BMJ Open; 2022 Sep; 12(9):e064545. PubMed ID: 36137621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A qualitative analysis of student pharmacists' perceptions working in community settings during the COVID-19 pandemic.
    Bingham JM; Maldonado T; Axon DR
    Curr Pharm Teach Learn; 2024 Sep; 16(9):102104. PubMed ID: 38789297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacists' role, work practices, and safety measures against COVID-19: A comparative study.
    Novak H; Tadić I; Falamić S; Ortner Hadžiabdić M
    J Am Pharm Assoc (2003); 2021; 61(4):398-407. PubMed ID: 33820717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recommendations and guidance for providing pharmaceutical care services during COVID-19 pandemic: A China perspective.
    Zheng SQ; Yang L; Zhou PX; Li HB; Liu F; Zhao RS
    Res Social Adm Pharm; 2021 Jan; 17(1):1819-1824. PubMed ID: 32249102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perspectives of clinical pharmacists on the provision of pharmaceutical care through telepharmacy services during COVID-19 pandemic in Qatar: A focus group.
    Alhmoud E; Al Khiyami D; Barazi R; Saad M; Al-Omari A; Awaisu A; El Enany R; Al Hail M
    PLoS One; 2022; 17(10):e0275627. PubMed ID: 36228028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community pharmacists' expanding roles in supporting patients before and during COVID-19: An exploratory qualitative study.
    Isenor JE; Cossette B; Murphy AL; Breton M; Mathews M; Moritz LR; Buote R; McCarthy L; Woodill L; Morrison B; Guénette L; Marshall EG
    Int J Clin Pharm; 2023 Feb; 45(1):64-78. PubMed ID: 36289174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Australian community pharmacists' experiences during the COVID-19 pandemic.
    Kanaani E; Salahudeen MS; Curtain C
    Int J Pharm Pract; 2023 Sep; 31(5):472-477. PubMed ID: 37348933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing Community Pharmacists' Perception on Readiness to Initiate Point-of-Care Testing for SARS-CoV-2 in New York State During the Pandemic.
    Ngwu RO; Lindeau R; Bielecki LM; Daly CJ
    J Pharm Pract; 2024 Apr; 37(2):324-334. PubMed ID: 36242519
    [No Abstract]   [Full Text] [Related]  

  • 20. "Never waste a good crisis": Opportunities and constraints from the COVID-19 pandemic on pharmacists' scope of practice.
    Chiu K; Thow AM; Bero L
    Res Social Adm Pharm; 2022 Sep; 18(9):3638-3648. PubMed ID: 35414485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.